Financials
- Fiscal year
- 2026
- Total assets
- €669,817
- Profit
- €15,526
- Solvency
- 75.3%
Total assets▲ 4.0%
Net result
20192026
Anglopharma
ActiveSummary
Anglopharma has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €504,483 and a net result of €15,526. Equity remains stable across the filed fiscal years (±2.5% per year). Its solvency ranks better than 85% of 311 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is < 0.1% (very low).
Overview
What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
How big
€669,817total assets 2026
- Staff
- 1.4 FTE
- Equity
- €504,483
- Profit
- €15,526
Turnover not published (abridged schema)
Who decides
Accounts 89 d early0 of 3 deeds read
Why 95- Sector Retail trade (NACE 47)+ Liquidity: current ratio 3.45, cash €223,629+ Founded in 1968+ Equity €504,483 (75.3% of total assets)Show the evidence
Checked score
Score 2026
95
/ 100
Excellent
Probability in this band: under 0.55%
Better than 64% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2025
Strong
Solvency
100=
equity 75.3% of total assets
Liquidity
83-1
short-term debt 24.4% · cash 33.4%
Profitability
57+54
return on assets 2.3%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
- Liquidity: current ratio 3.45, cash €223,629 lowers the probability
- Founded in 1968 lowers the probability for this profile
- Equity €504,483 (75.3% of total assets) lowers the probability
- Sector Retail trade (NACE 47) raises the probability
Credit up to €45,000 at 30 days acceptable
Liquidity ample (current ratio 3.45 against 4.05 in 2025; short-term debt: 24.4% and cash: 33.4% of total assets), and 24.7% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 92%, liquidity 86%, profitability 41%, growth against the median 36%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 03-06-2026, 89 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
89 d early
2025
22 d late
2024
25 d late
2023
29 d late
2022
22 d late
2021
28 d late
2020
60 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 14 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today. Usually files around 22 September (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
02-10-2026 today31-01-2027 close31-08-2027 deadline
- Annual accounts filedfiscal year 2026 · abbreviated…
- Back to profitnet €15,526
- Annual accounts filedfiscal year 2025 · abbreviated…
Key points
By topic
Timeline
- Events
- 14
- Since
- 2017
- Next accounts
- by 31-08-2027
- 03-06-2026Annual accounts filed
- 31-01-2026Back to profit
- 22-09-2025Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 01-01-1968
- Year ends
- 31-01
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.